Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $175.85 | 9 | 92.9% |
| Education | $13.35 | 1 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $53.82 | 3 | $0 (2024) |
| MILLICENT US INC | $28.42 | 2 | $0 (2024) |
| Exact Sciences Corporation | $26.97 | 1 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $24.27 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $22.52 | 1 | $0 (2023) |
| Paratek Pharmaceuticals, Inc. | $17.11 | 1 | $0 (2024) |
| ABBVIE INC. | $16.09 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $142.41 | 8 | Novo Nordisk Inc ($53.82) |
| 2023 | $46.79 | 2 | Bayer Healthcare Pharmaceuticals Inc. ($24.27) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: ANTIBIOTIC | ||||||
| 05/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Diabetes | ||||||
| 04/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Diabetes | ||||||
| 03/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 03/08/2024 | MILLICENT US INC | — | Education | In-kind items and services | $13.35 | General |
| 01/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Diabetes | ||||||
| 05/25/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Oncology | ||||||
| 04/27/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 13 | $2,678 | $719.40 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 13 | $2,678 | $719.40 | 26.9% |
About Michelle Mirasgeldi, APN
Michelle Mirasgeldi, APN is a Primary Care healthcare provider based in Denville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2023. The National Provider Identifier (NPI) number assigned to this provider is 1306545512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michelle Mirasgeldi, APN has received a total of $189.20 in payments from pharmaceutical and medical device companies, with $142.41 received in 2024. These payments were reported across 10 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($175.85).
As a Medicare-enrolled provider, Mirasgeldi has provided services to 11 Medicare beneficiaries, totaling 13 services with total Medicare billing of $719.40. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Primary Care
- Location Denville, NJ
- Active Since 02/27/2023
- Last Updated 11/09/2023
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1306545512
Products in Payments
- Rybelsus (Drug) $36.56
- Cologuard Collection Kit (Device) $26.97
- Nubeqa (Drug) $24.27
- Myrbetriq (Drug) $22.52
- Ozempic (Drug) $17.26
- NUZYRA (Drug) $17.11
- QULIPTA (Drug) $16.09
- FEMRING (Drug) $15.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.